Mast cells cultured from IL-3-treated mice show impaired responses to bacterial antigen stimulation

Inflammation Research

Volumn 61, Issue 1, 2012, Pages 79-85

  Vukman, Krisztina V ^a   Visnovitz, Tamás ^b   Adams, Paul N ^a   Metz, Martin ^c   Maurer, Marcus ^c   O'Neill, Sandra M ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

C57BL 6 mice; Ex vivo culture; Interleukin 3; Peritoneal mast cells

Indexed keywords

BACTERIAL ANTIGEN; BETA N ACETYLHEXOSAMINIDASE; BORDETELLA PERTUSSIS ANTIGEN; FC EPSILON RI; GAMMA INTERFERON; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OX40 LIGAND; STEM CELL FACTOR RECEPTOR; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL STIMULATION; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FLOW CYTOMETRY; IMMUNE RESPONSE; INCUBATION TIME; INTESTINE; LUNG; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEAL CAVITY; PERITONEUM MAST CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKELETAL MUSCLE; SPLEEN; SUPERNATANT; TISSUE SPECIFICITY;

ANIMALS; ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; CELL MEMBRANE; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INTERLEUKIN-3; LIPOPOLYSACCHARIDES; MAST CELLS; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PERITONEUM; SPLEEN; TIME FACTORS;

EID: 84857625799     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0394-6     Document Type: Article

References (29)

1. Weller CL, Collington SJ, Williams T, Lamb JR. Mast cells in health and disease. Clin Sci. 2011;120:473-84.
2. Galli SJ, Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol. 2010;40:1843-51.
3. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77:1033-79. (Pubitemid 27459579)
4. Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence. Curr Opin Immunol. 2007;19:31-8. (Pubitemid 46073696)
5. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol. 2010;10:440-52.
6. Echtenacher B, Männel DN, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nat Rev Immunol. 1996;381:75-7. (Pubitemid 26130005)
7. Siebenhaar F, Syska W, Weller K, Magerl M, Zuberbier T, Metz M, Maurer M. Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am J Pathol. 2007;170: 1910-6. (Pubitemid 47339265)
8. Marshall JS, King C, McCurdy JD. Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr Pharm Des. 2003;9:11-24. (Pubitemid 36131702)
9. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol. 2008;8:478-86. (Pubitemid 351733419)
10. Supajatura V, Ushio H, Nakao A, Akira S, Okumura K, Ra C, Ogawa H. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest. 2002;109: 1351-9. (Pubitemid 34546900)
11. Mielcarek N, Hörnquist EH, Johansson BR, Locht C, Abraham SN, Holmgren J. Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin. Cell Microbiol. 2001;3:181-8. (Pubitemid 32236935)
12. McCurdy JD, Lin T-J, Marshall JS. Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol. 2001;70:977-84. (Pubitemid 33151136)
13. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol. 2001;167:2250-6. (Pubitemid 32747537)
14. Matsushima H, Yamada N, Matsue H, Shimada S. TLR3-, TLR7- , and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol. 2004;173:531-41. (Pubitemid 38797381)
15. Hochdörfer T, Kuhny M, Zorn CN, Hendriks RW, Vanhaesebroeck B, Bohnacker T,Krystal G,HuberM.Activation of the PI3 K pathway increases TLR-induced TNF-a and IL-6 but reduces IL-1b production in mast cells. Cell Signal. 2011;23: 866-75.
16. Mrabet-Dahbi S, Metz M, Dudeck A, Zuberbier T, Maurer M. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp Dermatol. 2009;18:437-44.
17. Abe T, Sugaya H, Ishida K, Khan WI, Tasdemir I, Yoshimura K. Intestinal protection against Strongyloides ratti and mastocytosis induced by administration of interleukin-3 in mice. Immunology. 1993;80:116-21. (Pubitemid 23284198)
18. Ohmori K, Luo YC, Jia Y, Nishida J, Wang ZQ, Bunting KD, Wang DM, Huang H. IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bone marrow and by increasing the number of basophil/mast cell progenitors in the spleen. J Immunol. 2009;182:2835-41.
19. Mahon BP, Ryan MS, Griffin F, Mills KH. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun. 1996;64:5295-301. (Pubitemid 26403995)
20. Abe T, Nawa Y. Worm expulsion and mucosal mast cell response induced by repetitive IL-3 administration in Strongyloides rattiinfected nude mice. Immunology. 1988;63:181-5.
21. Csaba G. Mechanism of the formation of mast-cell granules. Acta Biol Acad Sci Hung. 1968;19:347-62.
22. Gersch C, Dewald O, Zoerlein M, Michael LH, Entman ML, Frangogiannis NG. Mast cells and macrophages in normal C57BL/6 mice. Histochem Cell Biol. 2002;118:41-9. (Pubitemid 34762318)
23. Wright HV, Bailey D, Kashyap M, Kepley CL, Drutskaya MS, Nedospasov SA, Ryan JJ. IL-3-mediated TNF-a production is necessary for mast cell development. J Immunol. 2006;176:2114-21. (Pubitemid 43201658)
24. Abe T, Ninamishima Y, Nawa Y. Induction of intestinal mastocytosis in nude mice by repeated injection of interleukin-3. Int Arch Allergy Appl Immunol. 1988;86:356-8.
25. Lantz CS, Min B, Tsai M, Chatterjea D, Dranoff G, Galli SJ. IL-3 is required for increases in blood basophils in nematode infection in mice and can enhance IgE-dependent IL-4 production by basophils in vitro. Lab Invest. 2008;88:1134-42.
26. Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC, Nawa Y, Dranoff G, Galli SJ. Role for interleukin-3 in mast cell and basophil development and immunity to parasites. Nature. 1998;392:90-3. (Pubitemid 28150595)
27. Chen B, Scheding S, Nakeff A, Ruan QY. Differential expression of mast cell growth factor receptor (c-kit) by peritoneal connective tissue-type mast cells and tissue culture-derived mast cells. J Leukoc Biol. 1994;55:596-602. (Pubitemid 24171726)
28. Galli SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor, and mast cells - what each is teaching us about the others. Am J Pathol. 1993;142:965-74. (Pubitemid 24060571)
29. Ugajin T, Kojima T, Mukai K, Obata K, Kawano Y, Minegishi Y, Eishi Y, Yokozeki H, Karasuyama H. Basophils preferentially express mouse mast cell protease 11 among the mast cell tryptase family in contrast to mast cells. J Leukoc Biol. 2009;86:1417-25.